ArticleReproductive sciences (Thousand Oaks, Calif.)2026
Cinnamaldehyde Attenuates Dehydroepiandrosterone-induced Apoptosis and Inflammatory Responses in a KGN Cell Model of Polycystic Ovary Syndrome.
Article in Reproductive sciences (Thousand Oaks, Calif.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polycystic ovary syndrome (PCOS) is a complex reproductive and metabolic disorder characterized in part by chronic low-grade inflammation and granulosa-cell dysfunction. New interventions that protect granulosa cells from hyperandrogenic injury are needed. Cinnamaldehyde (CA), a major bioactive component of cinnamon, has anti-inflammatory and cytoprotective properties; however, its effects in PCOS-related cell models remain unclear. We evaluated CA in human KGN granulosa-like cells treated with dehydroepiandrosterone (DHEA) to establish an in vitro PCOS-like model. CA increased cell viability and EdU incorporation in DHEA-treated cells, reduced the production and expression of TNF-α, IL-1β, and IL-6, and decreased apoptosis. CA also increased PI3K and Akt phosphorylation relative to DHEA treatment alone. These findings indicate that CA attenuates DHEA-induced inflammatory and apoptotic injury in KGN cells and that its effects are associated with restoration of PI3K/Akt signaling. CA therefore warrants further mechanistic evaluation as a potential modulator of PCOS-related granulosa-cell dysfunction.
Indexed as
Identifiers
42726396What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.